Eukaryotic Translation Initiation Factor 3 Subunit B Promotes Head And Neck Cancer Via CEBPB Translation
Abstract Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer type worldwide. Deregulation of mRNA translation is a frequent feature of cancer. Eukaryotic Translation Initiation Factor 3 Subunit B (EIF3B) has reported as oncogenes in cancer. However, the role of EIF3B in HNSCC remains unclear. Methods: In this study, the clinical significance of EIF3B expression in TCGA was analyzed. Then the expression of EIF3B was knockdown, and its role in HNSC was revealed. To explore the molecular mechanism of EIF3B, we applied RNA sequencing and proteomics, and deregulated pathways were acquired. RNA immunoprecipitation (RIP) sequencing was conducted to uncover the targeting mRNAs of EIF3B. Potential targets of EIF3B were validated with TCGA datasets.Results: EIF3B serves a hazardous prognostic marker in HNSCC. Besides, EIF3B promotes HNSCC proliferation and progression in vitro and in vivo. EIF3B promotes CEBPB translation and activate MAPK pathway. IL6R and CCNG2 is a target of EIF3B regulated CEBPB translation. Conclusion: In sum, this study reveals EIF3B as a novel oncogene in HNSCC, by promoting CEBPB translation and IL6R expression.